Clinical Trials Study
N/A
The Longevity Genes in Founder Populations Project
Conditions: EXTREME LONGEVITY
- Study #:
- NCT00707694
- Last Updated:
- 01/02/2026
- Recruitment Status:
- Recruiting
- Estimated Study Completion Date:
- 12/01/2032
Summary
We believe extreme longevity is due to specific genes which function to delay aging and prevent disease. The purpose of the research is to identify the genes/mutations associated with healthier aging; to understand the biological functions of these genes/mutations; and to develop therapies to replicate these preservative genetic activities in individuals who do not have the genetic profile for longevity.
Age: 65 Years and older
Gender: All
Start Date: 07/01/1998
Primary Completion Date (Estimated): 12/01/2032
Study Completion Date (Estimated): 12/01/2032
Accepts Healthy Volunteers: No
Trial Purpose and Description
Eligibility Criteria
Age: 65 Years and older
Gender: All
Accepts Healthy Volunteers: No
Inclusion criteria:
* Ashkenazi Jewish, age 95+,
* Offspring of person age 95+,
* Offspring of parents who died age 70 or younger.
Exclusion criteria:
* Non-Ashkenazis
Principal Investigator
Nir Barzilai